Edition:
India

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

3,798JPY
20 Sep 2019
Change (% chg)

¥41 (+1.09%)
Prev Close
¥3,757
Open
¥3,759
Day's High
¥3,814
Day's Low
¥3,744
Volume
7,566,900
Avg. Vol
5,201,937
52-wk High
¥4,943
52-wk Low
¥3,401

Summary

Name Age Since Current Position

Masahiro Sakane

78 2017 Independent Chairman of the Executive Board

Christophe Weber

52 2015 President, Chief Executive Officer, Representative Director

Constantine Saroukos

48 2019 Chief Financial Officer, Director

Masato Iwasaki

60 2019 President of Japan Pharma Business Unit, President of Subsidiary, Director

Andrew Plump

53 2019 President of Research & Development, Director

Yasuhiko Yamanaka

63 2016 Director

Emiko Azuma

60 2016 Independent Director

Olivier Bohuon

60 2019 Independent Director

Jean-Luc Butel

62 2016 Independent Director

Ian Clark

59 2019 Independent Director

Yoshiaki Fujimori

68 2016 Independent Director

Steven Gillis

66 2019 Independent Director

Koji Hatsukawa

67 2016 Independent Director

Shiro Kuniya

62 2016 Independent Director

Michel Orsinger

61 2016 Independent Director

Toshiyuki Shiga

65 2016 Independent Director

Tokumasa Takeda

2016 IR Contact Officer

Biographies

Name Description

Masahiro Sakane

Mr. Masahiro Sakane has been serving as Independent Chairman of the Executive Board in Takeda Pharmaceutical Company Limited since June 2017. He is also Chairman of the Nominating Committee of the Company. He is also serving as Independent Director in KAJIMA CORPORATION, and working for Komatsu Ltd.

Christophe Weber

Mr. Christophe Weber has been serving as President, Chief Executive Officer and Representative Director in Takeda Pharmaceutical Company Limited since April 1, 2015. He used to work for GlaxoSmithKline K.K.

Constantine Saroukos

Mr. Constantine Saroukos has been serving as Chief Financial Officer and Director in Takeda Pharmaceutical Company Limited since June 2019. He used to work for other companies.

Masato Iwasaki

Mr. Masato Iwasaki has been serving as President of Japan Pharma Business Unit and Director in Takeda Pharmaceutical Company Limited, as well as President and Representative Director of a subsidiary, since April 2019. He joined the Company in April 1985. His previous titles include Chief Director of Pharmaceutical Sales and Director of Product Strategy in the Company.

Andrew Plump

Mr. Andrew S. Plump has been serving as President of Research & Development and Director in Takeda Pharmaceutical Company Limited since January 2019. He is also serving as Vice President in a subsidiary. He used to work for other companies.

Yasuhiko Yamanaka

Mr. Yasuhiko Yamanaka has been serving as Director in Takeda Pharmaceutical Company Limited since June 2016. He is also a member of the Audit Committee and Compensation Committee of the Company. He joined the Company in April 1979. His previous titles include Director of Business Strategy, Chief Director of Pharmaceutical Sales and Managing Director in the Company.

Emiko Azuma

Ms. Emiko Azuma has been serving as Independent Director in Takeda Pharmaceutical Company Limited since June 2016. She is also a member of the Audit Committee and Nominating Committee of the Company. She is also serving as Independent Director in MetLife Insurance, KLA-Tencor Corporation, Sanken Electric Co., Ltd. and Rambus Incorporated, as well as Managing Director in Tomon Partners, LLC.

Olivier Bohuon

Mr. Olivier Bohuon has been serving as Independent Director in Takeda Pharmaceutical Company Limited since January 2019. He is also serving as Chairman and Independent Director in LEO Pharma, as well as Independent Director in Smiths Group plc.

Jean-Luc Butel

Mr. Jean-Luc Butel has been serving as Independent Director of Takeda Pharmaceutical Company Limited since June 2016. He is also serving as Independent Director in Novo Holdings as well as working for another company.

Ian Clark

Mr. Ian Clark has been serving as Independent Director in Takeda Pharmaceutical Company Limited since January 2019. He is also serving as Independent Director in 47 Co., Ltd., AcroBio Corporation, Guardant Health Inc., Asta Pharma and another company.

Yoshiaki Fujimori

Mr. Yoshiaki Fujimori has been serving as Independent Director of Takeda Pharmaceutical Company Limited since June 2016. He is also a member of the Compensation Committee of the Company. He is also serving as Independent Director in Toshiba Corporation, as well as working for LIXIL Group Corporation.

Steven Gillis

Mr. Steven Gillis has been serving as Independent Director in Takeda Pharmaceutical Company Limited since January 2019. He is also serving as Independent Director in a company, as well as Independent Director in another Company, and Managing Director in Arch Venture Partners.

Koji Hatsukawa

Mr. Koji Hatsukawa has been serving as Independent Director of Takeda Pharmaceutical Company Limited since June 2016. He is also Chairman of the Audit Committee of the Company. He is also working for Fujitsu Limited and The Norinchukin Bank.

Shiro Kuniya

Mr. Shiro Kuniya has been serving as Independent Director of Takeda Pharmaceutical Company Limited since June 2016. He is also a member of the Nominating Committee of the Company.He is also serving as Independent Director in Sony Financial Holdings Inc., Ebara Corporation and NEXON Co., Ltd., and is working for Oh-Ebashi LPC & Partners.

Michel Orsinger

Mr. Michel Orsinger has been serving as Independent Director in Takeda Pharmaceutical Company Limited since June 2016. He is also a member of the Audit Committee of the Company. He used to work for Johnson & Johnson.

Toshiyuki Shiga

Mr. Toshiyuki Shiga has been serving as Independent Director of Takeda Pharmaceutical Company Limited since June 2016. He is also Chairman of Compensation Committee of the Company. He is also serving as Chairman of the Board, Chief Executive Officer and Representative Director in Innovation Network Corporation of Japan.

Tokumasa Takeda